Escalating drug prices have affected safety net providers in serious ways. This report studies providers eligible to purchase prescription drugs at a discount under the 340B program, which requires manufacturers that receive reimbursement from Medicaid to provide reduced prices to more than...

Escalating drug prices have affected safety net providers in serious ways. This report studies providers eligible to purchase prescription drugs at a discount under the 340B program, which requires manufacturers that receive reimbursement from Medicaid to provide reduced prices to more than...